Exacerbation Risk in Asthma
NCT05501639 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1899
Last updated 2024-04-01
Summary
The purpose of this study is to conduct a comparative analysis of patients using Tiotropium in combination with Inhaled Corticosteroids (ICS) versus those that use long-acting β2-agonists (LABA) medication in combination with ICS.
Conditions
Interventions
- DRUG
-
tiotropium
tiotropium
- DRUG
-
long-acting β2-agonists (LABA)
long-acting β2-agonists (LABA)
- DRUG
-
inhaled corticosteroids (ICS)
inhaled corticosteroids (ICS)
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-14
- Primary Completion
- 2021-11-02
- Completion
- 2021-11-02
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
NCT01696071 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg
NCT00350207 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate the Effect of Inhaled Tiotropium Bromide on Neurokinin-A Induced Bronchoconstriction in Patients With Mild-to-moderate Asthma
NCT00557700 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
NCT01634113 ·Status: COMPLETED ·Phase: PHASE2
-
Steroids In Eosinophil Negative Asthma
NCT02066298 ·Status: COMPLETED ·Phase: PHASE3
-
Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma
NCT05113615 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
NCT01257230 ·Status: COMPLETED ·Phase: PHASE3
-
Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis
NCT02345993 ·Status: UNKNOWN ·Phase: PHASE4
-
A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
NCT01444430 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller
NCT04092582 ·Status: COMPLETED ·Phase: PHASE2
-
Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications
NCT00557180 ·Status: COMPLETED
-
Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129)
NCT00163332 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma
NCT02528214 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
NCT01383499 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid
NCT05292586 ·Status: COMPLETED ·Phase: PHASE3
-
Improving the Quality of Care for Asthma Patients at Risk of Exacerbations
NCT06596512 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults
NCT02030457 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
NCT01277523 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma
NCT05935332 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
NCT01634139 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
NCT02513160 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma
NCT00116103 ·Status: COMPLETED ·Phase: PHASE2
-
TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA
NCT02676076 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
NCT01634152 ·Status: COMPLETED ·Phase: PHASE3
-
Titratable Dosing in Moderate to Severe Asthmatics
NCT00651768 ·Status: COMPLETED ·Phase: PHASE3